Year: 2014
Type: review
Abstract: Primary sclerosing cholangitis (PSC) is a chronic cholangiopathy characterized by biliary fibrosis, development of cholestasis and end stage liver disease, high risk of malignancy, and frequent need for liver transplantation. The poor understanding of its pathogenesis is also reflected in the lack of effective medical treatment. Well-characterized animal models are utterly needed to develop novel pathogenetic concepts and study new treatment strategies. Currently there is no consensus on how to evaluate and characterize potential PSC models, which makes direct comparison of experimental results and effective exchange of study material between research groups difficult. The International Primary Sclerosing Cholangitis Study Group (IPSCSG) has therefore summarized these key issues in a position paper proposing standard requirements for the study of animal models of PSC.
Source: Journal of Hepatology
Institutions: Medical University of Graz, Amsterdam UMC Location University of Amsterdam, University of Amsterdam, University of Birmingham, Inserm, Centre de Recherche Saint-Antoine, Université Pierre-et-Marie-Curie, Düsseldorf University Hospital, Heinrich Heine University Düsseldorf, University Medical Center Hamburg-Eppendorf, University of Gothenburg, Oslo University Hospital, University of Bergen, University of Cambridge, Addenbrooke's Hospital, University Hospitals Birmingham NHS Foundation Trust, Queen Elizabeth Hospital Birmingham, Yale University, University of Milano-Bicocca, Medizinische Hochschule Hannover, Medical University of Vienna
Language: English
Topic: Liver Diseases and Immunity
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $5,500
OpenAlex ID: W1984988950
